Site Members can sign up for company wide alerts
Investigation Overview
January 20, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD), was announced concerning whether the takeover of CoLucid Pharmaceuticals Inc by Eli Lilly and Company for $46.50 per share is unfair to NASDAQ:CLCD stockholders. The investigation by a law firm concerns whether certain officers a...
You must register (for free) or login to view the entire investigation.